QUADRANT CAPITAL GROUP LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$36,930
-21.8%
803
-2.3%
0.00%
-20.0%
Q2 2023$47,241
+55.1%
822
+1.2%
0.01%
+66.7%
Q1 2023$30,450
+261.0%
812
+169.8%
0.00%
+200.0%
Q4 2022$8,434
-23.3%
301
-25.5%
0.00%0.0%
Q3 2022$11,000
+37.5%
404
+78.0%
0.00%0.0%
Q2 2022$8,000
-42.9%
227
-42.4%
0.00%
-50.0%
Q1 2022$14,000
+133.3%
394
+60.8%
0.00%
+100.0%
Q4 2021$6,000
-14.3%
245
-31.2%
0.00%0.0%
Q3 2021$7,000
+250.0%
356
+229.6%
0.00%
Q2 2021$2,0000.0%108
-8.5%
0.00%
Q1 2021$2,000
+100.0%
118
+114.5%
0.00%
Q4 2020$1,0000.0%550.0%0.00%
Q3 2020$1,0000.0%550.0%0.00%
Q2 2020$1,0000.0%550.0%0.00%
Q1 2020$1,000
-98.1%
55
-97.9%
0.00%
-100.0%
Q2 2019$54,000
+1.9%
2,6360.0%0.01%0.0%
Q1 2019$53,0002,6360.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders